| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 25.010 | 34.932 | 39.264 | 50.436 | 61.994 | 81.753 | 90.774 |
| Total Income - EUR | - | - | - | 25.010 | 34.932 | 39.264 | 50.436 | 61.994 | 93.883 | 90.775 |
| Total Expenses - EUR | - | - | - | 4.015 | 3.007 | 10.413 | 17.509 | 21.014 | 28.419 | 24.672 |
| Gross Profit/Loss - EUR | - | - | - | 20.995 | 31.925 | 28.851 | 32.927 | 40.980 | 65.464 | 66.103 |
| Net Profit/Loss - EUR | - | - | - | 20.245 | 30.877 | 27.673 | 31.414 | 39.331 | 64.526 | 63.380 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
Check the financial reports for the company - Klaroptic Vallmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 644 | 3.232 | 29.368 | 19.583 | 12.040 | 0 | 16.688 |
| Current Assets | - | - | - | 19.846 | 47.827 | 39.387 | 52.427 | 58.570 | 90.338 | 56.653 |
| Inventories | - | - | - | 0 | 0 | 910 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 3.094 | 2.826 | 0 | 0 | 24.536 | 60.897 | 24.368 |
| Cash | - | - | - | 16.752 | 45.001 | 37.600 | 51.570 | 33.174 | 28.584 | 31.432 |
| Shareholders Funds | - | - | - | 20.288 | 50.772 | 27.714 | 54.268 | 57.267 | 81.186 | 63.421 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 202 | 287 | 41.040 | 17.742 | 13.343 | 9.152 | 9.920 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Klaroptic Vallmed S.r.l.